Stocks
National Grid -4.0%: the buy signal stays in the green in week 5
National Grid stock slips 4.0%, while the buy signal in week 5 is still 0.82% up since entry. Our model indicates a full position size and places the next scaling-out window, for 10% of the position, in week 6.
Munich Re -1.9%: trade still 21.42% up since entry, coverage complete
Munich Re stock slips 1.9%, with the buy signal in week 21 and the trade in its management phase at 21.42% up. The model has already completed its coverage and, on this signal, expects a move of medium size.
Mercedes-Benz Group -7.7%: stock breaks its 52-week low, short up 8.88%
Mercedes-Benz Group stock sheds 7.7%, and the sell signal, now in week 8, is in its management phase. The stock broke below its 52-week low and closed under it, with the short 8.88% in profit, which our model reads as a sign of weakness.
London Stock Exchange Group -1.0%: buy signal in week 4, still in profit
London Stock Exchange Group stock loses 1.0% on the week, with the buy signal in week 4 and 1.60% up since entry. Our model indicates a standard position size and places the next scaling-out window, for 10%, in week 6.
Lloyds Banking Group -3.9%: the short is 13.04% in profit in week 9
Lloyds Banking Group stock drops 3.9%, while the sell signal, now in week 9, stays in its management phase. Our model sees a decline carving out lower lows and flags the 24-week low as the next floor to watch.
Infineon Technologies -8.9%: the managed short reaches a 28.62% gain in week 18
Infineon Technologies stock falls 8.9%, and the sell signal, now in week 18, stays in its management phase with the short up 28.62%. Our model notes that the 24-week low has already halted the decline once in recent weeks.
HSBC stock -8.9%: price breaks its 24-week low, short now up 14.44%
HSBC stock loses 8.9% on the week, and the sell signal, in week 7 and in its management phase, has the short 14.44% in profit. Our model flags a weekly close below the 24-week low, which it reads as a sign of weakness.
GSK -3.6%: buy signal in week 4, our model points to a full position size
GSK stock loses 3.6% on the week, with the buy signal in week 4 sitting 2.72% down since entry. Our model expects a narrow move, points to a full position size and places the next scaling-out window in week 6.
EXV6 -12.1%: the ETF breaks its 24-week low, short up 19.29%
EXV6, the European basic resources ETF, drops 12.1% while its sell signal, in week 7, stays in its management phase. Technical analysis: price broke below the 24-week low and closed under it, which our model reads as a sign of weakness.
Glencore -11.9%: close below the 24-week low, short now 19.89% in profit
Glencore stock drops 11.9%, and the sell signal, in week 8 and in its management phase, puts the short 19.89% in profit. Our model reads the close below the 24-week low as a sign of weakness, within a decline that is starting to make lower lows.
EXV4 -3.5%: the buy signal on the European health care ETF moves into week 4
EXV4, the European health care ETF, slips 3.5%, and its buy signal, in week 4, is still 3.06% up since entry. In our model's technical analysis, the next scaling-out window is due in week 6 and the indicated position size is full.
EXV3 -10.5%: the sell signal is in week 2, with the short up 7.56%
EXV3, the European technology ETF, drops 10.5% and the sell signal is in week 2, with the short up 7.56%. Our model rates opening a new short as high risk. Our technical analysis of the ETF continues week by week.
EXV2 -4%: short on the European telecoms ETF in its management phase, up 3.56%
EXV2, the European telecommunications ETF, falls 4% while its sell signal, now in week 7, is in the management phase. In our technical analysis the short is up 3.56%, and the model sees a decline under way, marked by lower lows.
EXV1 -7.4%: early-exit warning on the European banks ETF in confirmation week
EXV1, the European banks ETF, falls 7.4% and closes the buy signal's confirmation week lower. An early-exit warning kicks in this week, and for anyone weighing a fresh entry our model advises against the trade.